Home » Topics » BioWorld Science

BioWorld Science
RSS

Pharmacyclics reports interim phase I results for Antrin photoangioplasty for CAD

Sep. 7, 2001

Important new information on heart failure now available from Prous Science

Sep. 7, 2001

Emerging pharmaceutical company announces name change

Sep. 7, 2001

Synthetic SOD/catalase mimetic may prove useful in sideroblastic anemia

Sep. 7, 2001

GeneData and diaDexus establish functional genomic data analysis collaboration

Sep. 7, 2001

Major European launch announced for new CLL therapy

Sep. 7, 2001

Cialis NDA accepted for FDA review

Sep. 7, 2001

Pariet receives E.U. clearance for treatment of symptomatic GERD

Sep. 7, 2001

Xefo introduced by CeNeS in U.K.

Sep. 7, 2001

Advance in the design of anticancer G-quadruplex ligands reported at ACS meeting

Sep. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.